Advanced search
Publication Cover
Cancer Investigation Volume 38, 2020 - Issue 8-9
Submit an article Journal homepage
1,757
Views
6
CrossRef citations to date
0
Altmetric
Commentary

COVID-19, Cancer, and Consequences: Where Are We Now?

Nicole M. Kuderer
(Guest Editor) &
Gary H. LymanCorrespondence[email protected]
(Editor-in-Chief)
Pages 431-435 | Published online: 18 Sep 2020

References

  • Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337. doi:10.1016/S1470-2045(20)30096-6.
  • Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. doi:10.1183/13993003.01227-2020.
  • Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009;10(6):589–597. doi:10.1016/S1470-2045(09)70069-5.
  • Knisely A, Wu J, Laplan SJ, Zhou ZN, Melamed A, Tergas AI, et al. Coronovirus spectrum infections (COVID-19, MERS, SARS) in cancer patients: a systmatic review of the literature. Cancer Investig. 2020. doi:10.1080/07357907.2020.1809668.
  • Luo J, Rizvi H, Egger JV, Preeshagul IR, Wolchok JD, Hellmann MD, et al. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers. Cancer Discov. 2020;10(8):1121–1128. doi:10.1158/2159-8290.CD-20-0596.
  • Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020;10(7):935–941. doi:10.1158/2159-8290.CD-20-0516.
  • ACS. COVID-19 guidelines for triage of cancer surgery patients. 2020. [cited 2020 Sep 9]. Available from: https://www.facs.org/covid-19/clinical-guidance/elective-case/cancer-surgery.
  • ASCO. COVID-19 patient care information. 2020. [cited 2020 Sep 9]. Available from: https://www.asco.org/asco-coronavirus-information/care-individuals-cancer-during-covid-19.
  • ASTRO. COVID-19 Recommendations. 2020. [cited 2020 Sep 9]. Available from: https://www.astro.org/Daily-Practice/COVID-19-Recommendations-and-Information/Clinical-Guidance.
  • Schrag D, Hershman DL, Basch E. Oncology practice during the COVID-19 pandemic. JAMA. 2020;323(20):2005. doi:10.1001/jama.2020.6236.
  • Desai A, Kuderer NM, Lyman GH. Crowdsourcing in crisis: rising to the occasion. JCO Clin Cancer Inform. 2020;4:551–554. doi:10.1200/CCI.20.00054.
  • Desai A, Warner J, Kuderer N, Thompson M, Painter C, Lyman G, et al. Crowdsourcing a crisis response for COVID-19 in oncology. Nat Cancer. 2020;1(5):473–474. doi:10.1038/s43018-020-0065-z.
  • Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–1918. doi:10.1016/S0140-6736(20)31187-9.
  • Rivera DR, Peters S, Panagiotou OA, Shah DP, Kuderer NM, Hsu C-Y, et al. Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study. Cancer Discov. 2020. doi:10.1158/2159-8290.CD-20-0941.
  • Lee LY, Cazier J-B, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926. doi:10.1016/S0140-6736(20)31173-9.
  • Garassino MC, Whisenant JG, Huang LC, Trama A, Torri V, Agustoni F, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21(7):914–922. doi:10.1016/S1470-2045(20)30314-4.
  • Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020. doi:10.1016/S2352-3026(20)30251-9.
  • Lyman GH. Providing oncology care during the COVID-19 pandemic. Clin Adv Hematol Oncol. 2020;18(5):262–265.
  • Griffiths EA, Alwan LM, Bachiashvili K, Brown A, Cool R, Curtin P, et al. Considerations for use of hematopoietic growth factors in patients with cancer related to the COVID-19 pandemic. J Natl Comp Cancer Ntwk. 2020;18:1–4.
  • Kuderer NM, Lyman GH. Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy. J Natl Cancer Inst. 2011;103(12):910–913. doi:10.1093/jnci/djr195.
  • Lyman GH, Kuderer NM. Personalized cancer supportive care in COVID-19 era. Ann Oncol. 2020;31(7):835–837. doi:10.1016/j.annonc.2020.05.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.